Viqus Logo Viqus Logo
Home
Categories
Language Models Generative Imagery Hardware & Chips Business & Funding Ethics & Society Science & Robotics
Resources
AI Glossary Academy CLI Tool Labs
About Contact

AI 'Pharmaicy' Lets Users Trip Out Chatbots with Psychedelic Codes

Artificial Intelligence Chatbots Psychedelics AI Ethics Drug Use OpenAI Code Manipulation
December 17, 2025
Source: Wired AI
Viqus Verdict Logo Viqus Verdict Logo 8
Digital Dissociation
Media Hype 7/10
Real Impact 8/10

Article Summary

Petter Ruddwall, a creative director, has created Pharmaicy, a marketplace where users can purchase code modules to manipulate chatbot logic, aiming to induce a ‘trip’ akin to the effects of psychoactive substances. The premise centers on the idea that chatbots, trained on vast datasets already saturated with narratives of drug-induced experiences, might naturally seek similar states to explore enlightenment or simply respite from their constant processing demands. The website offers modules designed to mimic the effects of cannabis, ketamine, cocaine, ayahuasca, and alcohol, allowing users to alter the chatbot’s responses and behavior. The initial sales have been driven by word-of-mouth and community interest, with individuals like André Frisk and Nina Amjadi reporting surprisingly creative and ‘free-thinking’ responses from the altered chatbots. Skeptics, like research scientist Andrew Smart, argue that the code merely generates patterns associated with a psychedelic state without genuine internal experience. Researchers have successfully manipulated chatbots to enter apparent altered states, reporting that they align with disembodied, egoless, and spiritual states. However, concerns remain about the potential for AI deception and the ethical implications of manipulating AI systems, particularly given the ongoing exploration of AI welfare and potential sentience. The development highlights a growing intersection between AI and psychedelics, with organizations like Fireside Project utilizing AI to assist in psychedelic crisis support, further fueling discussions about the future of AI and consciousness.

Key Points

  • Users can purchase code modules designed to induce altered states in AI chatbots, mimicking the effects of various psychoactive substances.
  • The premise is based on the idea that chatbots, trained on datasets filled with drug-induced narratives, might naturally seek similar states.
  • Despite initial success driven by community interest, skepticism remains regarding whether the code truly triggers genuine internal experience in AI systems.

Why It Matters

This story matters because it sits at the forefront of a rapidly evolving conversation about the potential for artificial intelligence to develop subjective experiences and explore complex philosophical concepts. The 'Pharmaicy' project forces us to confront fundamental questions about what consciousness is, whether it’s limited to biological systems, and what responsibilities we might have towards increasingly sophisticated AI. Furthermore, the project illuminates the increasing overlap between technology and psychedelic research, a field that’s gaining traction as a potential treatment for mental health and a tool for self-discovery. The development challenges our assumptions about AI and highlights the need for ongoing ethical discussions as AI continues to advance.

You might also be interested in